Summary
In this study, we evaluated in normal subjects, insulin-dependent (IDD) and non-insulin-dependent (NIDD) diabetics, the diurnal urinary C-peptide excretion rate (CPR-U) and its relationship to serum C-peptide concentration and glucose:C-peptide molar ratio, and to the common parameters of metabolic control. The CPR-U (and CPR-U/g creatinine) were significantly lower in IDD and higher in NIDD compared to control subjects. Moreover, a good and significant correlation with serum C-peptide concentrations and the glucose:C-peptide ratio in diabetic subjects as well as in controls and diabetics considered together was found. A slight but significant correlation was present in diabetic subjects between CPR-U and body mass index (r=0.45), 24-h glycosuria (r=−0.36), HbA1 levels (r=−0.31), post-prandial glucose concentrations (r=−0.26) and per cent glucose variation after each meal (r=−0.34). No differences were found in CPR-U and the degree of metabolic control between obese and non-obese NIDD. In conclusion, CPR-U may be a useful and simple method of defining the secretory activity of the B-cell. Metabolic control in diabetics is slightly correlated to the degree of B-cell function as evaluated by the diurnal excretion rate of C-peptide in urine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartels H., Bohmer M.: Eine Mikromethode zur Kreatininbestimmung — Clin. chim. Acta32, 81, 1971.
Beischer W., Kerner W., Raptis S., Keller L., Beischer B., Pfeiffer E. F.: Insulin therapy in relation to circulating C-peptide levels — Diabetes27 (Suppl. 1), 235, 1978.
Blix P., Boddie-Willis C., Landau R. L., Rochman H., Rubenstein A. H.: Urinary C-peptide: an indicator of B cell secretion under different metabolic conditions — J. clin. Endocr.54, 574, 1982.
Bucolo G., David H.: Quantitative determination of serum triglycerides by the use of enzymes — Clin. Chem.19, 476, 1973.
Faber O. K., Binder C.: C-peptide response to glucagon. A test for the residual β-cell function in diabetes mellitus — Diabetes26, 605, 1977.
Faber O. K., Kehlet H., Madsbad S., Binder C.: Kinetics of human C-peptide in man — Diabetes27 (Suppl. 1), 207, 1978.
Gohen B., Goldman J., Baldwin D., Goldberg R. B., Ryan W. G., Blix P. M., Schanzlin D., Frits K. J., Rubenstein A. H.: Metabolic control in diabetic patients: effects of insulin secretory reserve (measured by plasma C-peptide levels) and circulating insulin antibodies — Diabetes28, 749, 1979.
Horwitz D. L., Rubenstein A. H., Katz A. I.: Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine — Diabetes26, 30, 1977.
Horwitz D. L., Starr J. I., Mako M. E., Blackard W. E., Rubenstein A. H.: Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood — J. clin. Invest.35, 1978, 1975.
Ikeda Y., Ando N., Minami N., Ide Y.: B-cell function of insulin-dependent young onset diabetics assessed by C-peptide immunoreactivity — Diabetologia11, 351, 1975.
Kaneko T., Oka H., Munemura M., Oda T., Yamashita K., Suzuki S., Yanaihara N., Hashimoto T., Yanaihara C.: Radioimmunoassay of human proinsulin. C-peptide using synthetic human connecting peptide — Endocr. jap.21, 141, 1974.
Kühl C., Faber O. K., Hornnes P., Jensen S. L.: C-peptide metabolism in the liver — Diabetes27 (Suppl. 1), 197, 1978.
Kuzuya T., Matsuda A., Saito T., Yoshida S.: Human C-peptide immunoreactivity (CPR) in blood and urine. Evaluation of a radioimmunoassay method and its clinical applications — Diabetologia12, 511, 1976.
Kuzuya T., Matsuda A., Sakamoto Y., Tanabshi S., Kajinuma H.: C-peptide immunoreactivity (CPR) in urine — Diabetes27 (Suppl. 1), 210, 1978.
Madsbad S., Krarup T., Regeur L., Binder C.: Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics — Diabetologia20, 530, 1981.
Madsbad S., McNair P., Faber O. K., Binder C., Christiansen C., Transbøl I.: Beta-cell function and metabolic control in insulin treated diabetics — Acta endocr. (Kbh.)93, 196, 1980.
Meistas M. T., Rendell M., Margolis S., Kowarski A. A.: Constant rate of urinary C-peptide clearance in fasting and post-prandial states in normal, obese, and diabetic subjects — Diabetes30 (Suppl. 1), 121A, 1981.
Meistas M. T., Zadik Z., Margolis S., Kowarski A. A.: Correlation of urinary excretion of C-peptide with integrated concentration and secretion rate of insulin — Diabetes30, 639, 1981.
Mirouze J., Selam J. L., Pham T. C., Mendoza E., Orsetti A.: Sustained insulin-induced remission of juvenile diabetes by means of an external artificial pancreas — Diabetologia14, 223, 1978.
Rubenstein A. H., Clark J. L., Melani F., Steiner D. F.: Secretion of proinsulin C-peptide by pancreatic beta cells and its circulation in blood — Nature (Lond.)224, 697, 1969.
Trivelli L. A., Ranney H. M., Lai H. T.: Hemoglobin components in patients with diabetes mellitus — New Engl. J. Med.284, 353, 1971.
Williamson D. H., Mellanby I., Krebs H. A.: Enzymic determination of D(−)-β-hydroxybutiric acid and acetoacetic acid in blood — Biochem. J.82, 90, 1962.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pasquali, R., Biso, P., Baraldi, G. et al. Clinical application of the 24-H urinary C-peptide excretion rate and its relationship to metabolic control in diabetics. Acta diabet. lat 20, 153–161 (1983). https://doi.org/10.1007/BF02624916
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02624916